PD-L1 Antikörper (AA 61-160)
Kurzübersicht für PD-L1 Antikörper (AA 61-160) (ABIN1715049)
Target
Alle PD-L1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 61-160
-
Kreuzreaktivität
- Human, Maus, Ratte
-
Homologie
- Cow,Pig,Horse,Rabbit
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human CD274
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
WB 1:300-5000
FCM 1:20-100 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- PD-L1 (CD274 (PD-L1))
-
Andere Bezeichnung
- CD274
-
Hintergrund
-
Synonyms: B7-H1, PD-L1, CD274, Programmed cell death 1 ligand 1, Programmed death ligand 1, PD-L1, PDCD1 ligand 1, B7 homolog 1, B7-H1, Programmed death ligand 1, PD1L1_HUMAN.
Background: Programmed cell death 1 ligand 1(Programmed death ligand 1, PD-L1, PDCD1 ligand 1, B7 homolog 1, B7-H1, CD274) involved in the costimulatory signal, essential for T lymphocyte proliferation and production of IL10 and IFNG, in an IL2-dependent and a PDCD1-independent manner. Interaction with PDCD1 inhibit T-cell proliferation and cytokine production.
-
Gen-ID
- 8324
-
Pathways
- Cancer Immune Checkpoints
Target
-